Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
N0263115165
Study information
Scientific title
Acronym
Study hypothesis
Is Agent A better treatment than Agent B for patients with mild moderate falciparum malaria?
Ethics approval
Not provided at time of registration
Study design
Randomised controlled trial
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Not specified
Trial type
Treatment
Patient information sheet
Condition
Infections and Infestations: Malaria
Intervention
Randomised controlled trial:
A. Quinine and Fabsidar
B. Malarone
Intervention type
Drug
Phase
Not Specified
Drug names
Quinine, Fabsidar, Malarone
Primary outcome measures
1. Time to full recovery
2. Side effects of treatment
3. Relapse of malaria.
Secondary outcome measures
Not provided at time of registration
Overall trial start date
01/07/2002
Overall trial end date
01/07/2006
Reason abandoned
Eligibility
Participant inclusion criteria
400 Patients from Infectious/Tropical Diseases.
Participant type
Patient
Age group
Not Specified
Gender
Not Specified
Target number of participants
400
Participant exclusion criteria
Not provided at time of registration
Recruitment start date
01/07/2002
Recruitment end date
01/07/2006
Locations
Countries of recruitment
United Kingdom
Trial participating centre
Hospital for Tropical Diseases
London
WC1E 6JD
United Kingdom
Sponsor information
Organisation
Department of Health (UK)
Sponsor details
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
Sponsor type
Government
Website
Funders
Funder type
Government
Funder name
University College London Hospitals NHS Trust (UK)
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Not provided at time of registration
Intention to publish date
Participant level data
Not provided at time of registration
Results - basic reporting
Publication summary